Form DRSLTR - Correspondence Related to Draft Registration Statement:
SEC Accession No. 0000950123-21-008071
Filing Date
2021-06-21
Accepted
2021-06-21 21:42:57
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRSLTR 36664
2 GRAPHIC g105292snap085.jpg GRAPHIC 3471
  Complete submission text file 0000950123-21-008071.txt   42518
Mailing Address 23515 NE NOVELTY HILL ROAD SUITE B221 #125 REDMOND WA 98053
Business Address 23515 NE NOVELTY HILL ROAD SUITE B221 #125 REDMOND WA 98053 425-276-2300
Eliem Therapeutics, Inc. (Filer) CIK: 0001768446 (see all company filings)

EIN.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRSLTR
SIC: 2834 Pharmaceutical Preparations